Sophie Vandebroek V - 09 May 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Sophie V. Vandebroek
Issuer symbol
IDXX
Transactions as of
09 May 2025
Net transactions value
-$265,714
Form type
4
Filing time
13 May 2025, 17:00:17 UTC
Previous filing
08 May 2025
Next filing
19 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vandebroek Sophie V. Director ONE IDEXX DRIVE, WESTBROOK /s/ Lily J. Lu, Attorney-in-Fact for Sophie V. Vandebroek 13 May 2025 0001442078

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $362,712 +1,279 +110% $283.59 2,446 09 May 2025 Direct
transaction IDXX Common Stock Sale $628,425 -1,279 -52% $491.34 1,167 09 May 2025 Direct
holding IDXX Common Stock 8,173 09 May 2025 By Sophie V. Vandebroek Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise -1,279 -100% 0 09 May 2025 Common Stock 1,279 $283.59 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event was earlier.
F2 Not applicable.